Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.33 USD | +3.61% | -7.32% | -43.33% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.33% | 716M | |
+4.97% | 109B | |
+11.20% | 105B | |
-0.38% | 22.25B | |
-12.33% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.97% | 16.85B | |
+4.46% | 13.76B | |
+34.90% | 12.46B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Sage Therapeutics to $50 From $55, Maintains Neutral Rating